Pathologist: Zeying Du, MD, PhD | Loyola Medicine

COVID-19 (Coronavirus) Update

Loyola Medicine is resuming select health care services. Learn more about resumption of services.

Zeying Du, MD, PhD

Pathology

Assistant Professor
Director, HLA Laboratory

Languages Spoken

English, Chinese

Clinical Expertise

  • HLA Testing

About Dr. Du

Interests
Travel, Movies

Medical Education

Medical School
Third Military Medical University, China
Residency
Guangzhou General Hospital
China - Internal Medicine: Clinical Pharmacology
Fellowship

Board Certification

Research

  • Plasma cell densities and glomerular filtration rates predict renal allograft outcomes following acute rejection Chang, A.; Moore, J. M.; Cowan, M. L.; Josephson, M. A.; Chon, W. J.; Sciammas, R.; Du, Z.; Marino, S. R.; Meehan, S. M.; Millis, M.; David, M. Z.; Williams, J. W.; Chong, A. S., Transplant international : official journal of the European Society for Organ Transplantation
  • Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis Bonagura, V. R.; Du, Z.; Ashouri, E.; Luo, L.; Hatam, L. J.; DeVoti, J. A.; Rosenthal, D. W.; Steinberg, B. M.; Abramson, A. L.; Gjertson, D. W.; Reed, E. F.; Rajalingam, R., Human immunology
  • Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals Levinson, R. D.; Du, Z.; Luo, L.; Monnet, D.; Tabary, T.; Brezin, A. P.; Zhao, L.; Gjertson, D. W.; Holland, G. N.; Reed, E. F.; Cohen, J. H.; Rajalingam, R., Genes and immunity
View All ResearchShow Less
  • Distinct diversity of KIR genes in three southern Indian populations: comparison with world populations revealed a link between KIR gene content and pre-historic human migrations Rajalingam, R.; Du, Z.; Meenagh, A.; Luo, L.; Kavitha, V. J.; Pavithra-Arulvani, R.; Vidhyalakshmi, A.; Sharma, S. K.; Balazs, I.; Reed, E. F.; Pitchappan, R. M.; Middleton, D., Immunogenetics
  • KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease Levinson, R. D.; Du, Z.; Luo, L.; Holland, G. N.; Rao, N. A.; Reed, E. F.; Rajalingam, R., Human immunology
  • KIR2DL5 alleles mark certain combination of activating KIR genes Du, Z.; Sharma, S. K.; Spellman, S.; Reed, E. F.; Rajalingam, R., Genes and immunity
  • Chain-terminating natural mutations affect the function of activating KIR receptors 3DS1 and 2DS3 Luo, L.; Du, Z.; Sharma, S. K.; Cullen, R.; Spellman, S.; Reed, E. F.; Rajalingam, R., Immunogenetics
  • Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans Du, Z.; Gjertson, D. W.; Reed, E. F.; Rajalingam, R., Immunogenetics
  • Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts Veale, J. L.; Liang, L. W.; Zhang, Q.; Gjertson, D. W.; Du, Z.; Bloomquist, E. W.; Jia, J.; Qian, L.; Wilkinson, A. H.; Danovitch, G. M.; Pham, P. T.; Rosenthal, J. T.; Lassman, C. R.; Braun, J.; Reed, E. F.; Gritsch, H. A., Human immunology
  • Analysis of triptolide-regulated gene expression in Jurkat cells by complementary DNA microarray Du, Z. Y.; Li, X. Y.; Li, Y. C.; Wang, S. Y., Acta Pharmacologica Sinica